239 related articles for article (PubMed ID: 17433637)
1. The hypoxic tumour microenvironment, patient selection and hypoxia-modifying treatments.
Hoogsteen IJ; Marres HA; van der Kogel AJ; Kaanders JH
Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):385-96. PubMed ID: 17433637
[TBL] [Abstract][Full Text] [Related]
2. Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review.
Hoogsteen IJ; Marres HA; Bussink J; van der Kogel AJ; Kaanders JH
Head Neck; 2007 Jun; 29(6):591-604. PubMed ID: 17252597
[TBL] [Abstract][Full Text] [Related]
3. Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide.
Saunders M; Dische S
Br J Cancer Suppl; 1996 Jul; 27():S271-8. PubMed ID: 8763896
[TBL] [Abstract][Full Text] [Related]
4. Implementation of hypoxia measurement into lung cancer therapy.
Meng X; Kong FM; Yu J
Lung Cancer; 2012 Feb; 75(2):146-50. PubMed ID: 22001441
[TBL] [Abstract][Full Text] [Related]
5. [Anemia and radiotherapy].
Pasquier D; Lartigau E
Bull Cancer; 2003 Apr; 90 Spec No():S152-7. PubMed ID: 12856427
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia in head and neck cancer: how much, how important?
Janssen HL; Haustermans KM; Balm AJ; Begg AC
Head Neck; 2005 Jul; 27(7):622-38. PubMed ID: 15952198
[TBL] [Abstract][Full Text] [Related]
7. Clinical studies of hypoxia modification in radiotherapy.
Kaanders JH; Bussink J; van der Kogel AJ
Semin Radiat Oncol; 2004 Jul; 14(3):233-40. PubMed ID: 15254866
[TBL] [Abstract][Full Text] [Related]
8. Hyperthermia: a potent enhancer of radiotherapy.
Horsman MR; Overgaard J
Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):418-26. PubMed ID: 17493790
[TBL] [Abstract][Full Text] [Related]
9. Chemical radiosensitizers for use in radiotherapy.
Wardman P
Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):397-417. PubMed ID: 17478086
[TBL] [Abstract][Full Text] [Related]
10. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.
De Ridder M; Van Esch G; Engels B; Verovski V; Storme G
Bull Cancer; 2008 Mar; 95(3):282-91. PubMed ID: 18390408
[TBL] [Abstract][Full Text] [Related]
11. The effects of hypoxia on the theoretical modelling of tumour control probability.
Daşu A; Toma-Daşu I; Karlsson M
Acta Oncol; 2005; 44(6):563-71. PubMed ID: 16165915
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment.
Moeller BJ; Richardson RA; Dewhirst MW
Cancer Metastasis Rev; 2007 Jun; 26(2):241-8. PubMed ID: 17440683
[TBL] [Abstract][Full Text] [Related]
13. [The Oxygen effect: an old new target?].
Lartigau E; Dewas S; Gras L
Cancer Radiother; 2008 Jan; 12(1):42-9. PubMed ID: 18261946
[TBL] [Abstract][Full Text] [Related]
14. Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.
Ebbesen P; Pettersen EO; Gorr TA; Jobst G; Williams K; Kieninger J; Wenger RH; Pastorekova S; Dubois L; Lambin P; Wouters BG; Van Den Beucken T; Supuran CT; Poellinger L; Ratcliffe P; Kanopka A; Görlach A; Gasmann M; Harris AL; Maxwell P; Scozzafava A
J Enzyme Inhib Med Chem; 2009 Apr; 24 Suppl 1():1-39. PubMed ID: 19330638
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia inducible factor-1 alpha and vascular endothelial growth factor expression are associated with a poor prognosis in patients with nasopharyngeal carcinoma receiving radiotherapy with carbogen and nicotinamide.
Xueguan L; Xiaoshen W; Yongsheng Z; Chaosu H; Chunying S; Yan F
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):606-12. PubMed ID: 18692368
[TBL] [Abstract][Full Text] [Related]
16. Physiologic mechanisms of therapeutic resistance. Blood flow and hypoxia.
Teicher BA
Hematol Oncol Clin North Am; 1995 Apr; 9(2):475-506. PubMed ID: 7642474
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy?
Harrison L; Blackwell K
Oncologist; 2004; 9 Suppl 5():31-40. PubMed ID: 15591420
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia in cancer: significance and impact on clinical outcome.
Vaupel P; Mayer A
Cancer Metastasis Rev; 2007 Jun; 26(2):225-39. PubMed ID: 17440684
[TBL] [Abstract][Full Text] [Related]
19. Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response.
Vaupel P; Harrison L
Oncologist; 2004; 9 Suppl 5():4-9. PubMed ID: 15591417
[TBL] [Abstract][Full Text] [Related]
20. Single-cell-based computer simulation of the oxygen-dependent tumour response to irradiation.
Harting C; Peschke P; Borkenstein K; Karger CP
Phys Med Biol; 2007 Aug; 52(16):4775-89. PubMed ID: 17671335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
